XML 56 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended 147 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Cash flows from operating activities:        
Loss for the period $ (9,796,853) $ (2,772,307) $ (2,364,339) $ (25,086,679)
Adjustments to reconcile loss for the period to net cash used in operating activities:        
Depreciation 33,684 25,546 23,045 191,717
Increase (decrease) in liability for employee rights upon retirement (9,959) (17,237) 1,127 196,506
Stock-based compensation 35,619 349,522 378,072 1,616,044
Stock-based interest compensation to convertible notes holders          1,214,943
Issuance costs allocated to warrants with down-round protection 390,928     390,928
Change in the fair value of warrants issued with down-round protection 6,251,242 (35,892)    6,215,350
Linkage difference on principal of loans from stockholders 14,382 9,849 24,934 201,280
Interest on convertible notes          78,192
Gain on sale of property and equipment          (912)
Gain from trading marketable securities          (12,920)
Changes in assets and liabilities:        
Decrease (increase) in other current assets (5,234) 14,106 (23,968) (74,652)
Increase (decrease) in accounts payable (77,259) 48,850 64,697 44,733
Increase (decrease) in other current liabilities (54,317) 80,574 (19,681) 233,643
Net cash used in operating activities (3,217,767) (2,296,989) (1,916,113) (14,791,827)
Cash flows from investment activities:        
Decrease (increase) in funds in respect of employee rights upon retirement (40,029) (6,387) 14,436 (149,221)
Purchase of property and equipment (64,252) (11,347) (54,619) (284,372)
Proceeds from sale of property and equipment          4,791
Investment in marketable securities          (388,732)
Proceeds from sale of marketable securities          406,995
Short-term loan granted to related party, net of repayments          (14,252)
Net cash used in investment activities (104,281) (17,734) (40,183) (424,791)
Cash flows from financing activities        
Credit from banking institutions (repayment) (38,801) 36,348 (18,669) (8,671)
Proceeds from issuance of convertible notes          1,144,000
Repayment of convertible notes          (527,396)
Proceeds from issuance of Common Stock, net of issuance expenses    917,179 2,401,214 11,323,559
Dividend to Preferred Stockholders (288,248)       (288,248)
Proceeds allocated to convertible Preferred Stock, net of issuance expenses 3,960,958       3,960,958
Proceeds allocated to warrants with down-round protection, net of issuance expenses 1,421,983       1,421,983
Proceeds from stockholders loans          347,742
Net cash provided by financing activities 5,055,892 953,527 2,382,545 17,373,927
Effect of exchange rate changes on cash and cash equivalents 108,656 8,103 (23,993) 228,602
Increase (decrease) in cash and cash equivalents 1,842,500 (1,353,093) 402,256 2,385,911
Cash and cash equivalents at beginning of the period 543,411 1,896,504 1,494,248   
Cash and cash equivalents at end of the period $ 2,385,911 $ 543,411 $ 1,896,504 $ 2,385,911